Christopher Durant Turner, Chief Medical Officer at Nuvalent, Inc. (NUVL), sold 14,390 shares at $51.32 ($775K) on 2023-10-04, disclosed to the SEC on 2023-10-06.
Scheduled sale ($775k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $51.32 | 2,665 | $137K | 17.6% |
| 2 | $51.32 | 2,665 | $137K | 17.6% |
| 3 | $53.70 | 2,265 | $122K | 15.7% |
| 4 | $53.70 | 2,265 | $122K | 15.7% |
| 5 | $54.32 | 600 | $33K | 4.2% |
| 6 | $55.84 | 500 |
| $28K |
| 3.6% |
| 7 | $57.18 | 500 | $29K | 3.7% |
| 8 | $57.70 | 1,465 | $85K | 10.9% |
| 9 | $57.70 | 1,465 | $85K | 10.9% |
| Total | $53.85 avg | 14,390 | $775K | 100% |
| Filing → |
| NUVL | SELL | 2023-07-28 | $482K | — | Filing → |
| NUVL | SELL | 2023-07-24 | $14K | — | Filing → |
| NUVL | SELL | 2023-06-07 | $918K | — | Filing → |